BMS has reported topline outcomes from the ARISE trial of Cobenfy as an adjunctive treatment to atypical antipsychotics for ...

Cobenfy’s late-stage flop is BMS’ second high-profile failure in as many weeks. The pharma announced last week that Camzyos ...

US pharma major Bristol Myers Squibb (NYSE: BMY) saw its shares fall 4% in after-hours trading on Tuesday, after it announced ...

The new data – from the ARISE trial – found that Cobenfy wasn't statistically better than placebo at improving the widely ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been recommended by the National ...

The integration of digital technology is transforming the EV battery electrical testing equipment market, facilitating ...

The stock's rise snapped a four-day losing streak.

Akshay Kumar's Kesari Chapter 2 managed to pull the right magical charm, surpassing1st Tuesday BMS sales of all Hindi films except one.

CSIO has announced that Gore Mutual Insurance Company has received its eDocs Certification, confirming that the insurer’s ...

Digital technology integration is revolutionizing testing methodologies, facilitating real-time diagnostics. As battery technologies advance, manufacturers invest in sophisticated testing equipment ...

Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...

Berkshire Music School (BMS) will present a performance featuring Grammy-nominated alumnus Matt Cusson on April 26, 2025, at ...